Spears Kelvin 4

What Happened

Kelvin Spears, a director of Nutex Health (NUTX), made a small open-market purchase of 10 shares on March 17, 2026, at $94.46 per share for a total of $945. The report also shows an earlier transaction (dated March 10, 2026) where Spears exercised/converted a derivative instrument resulting in 116 shares acquired at an exercise price of $0.00 (total $0).

This filing combines a routine purchase (which some investors view as a modest bullish signal) with a conversion/settlement of previously held derivative awards. The Form 4 was filed on March 18, 2026 and is a correction related to RSU ownership reported earlier.

Key Details

• Transactions:
  • Mar 17, 2026 — Open-market purchase (Code P): 10 shares @ $94.46 = $945.
  • Mar 10, 2026 — Exercise/conversion of derivative (Code M): 116 shares @ $0.00 = $0.
• Filing date / report period: Filed 2026-03-18 for period ending 2026-03-17 (timely).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote F1: This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following an RSU grant reported on a March 11, 2026 Form 4 related to the March 10, 2026 transaction.
• No indication of a 10b5-1 plan, tax withholding sale, or gift in this filing.

Context

• The "M" code indicates an exercise or conversion of a derivative. Because the exercise price is listed as $0.00 and the footnote references RSUs, this likely reflects RSU vesting or conversion into shares rather than a paid option exercise.
• Small open-market buys like this are factual data points but do not alone indicate a change in company outlook. There is no evidence in this filing that shares were immediately sold (i.e., cashless exercise followed by sale).